Scott W Woods MD

Professor of Psychiatry and Associate Professor of Diagnostic Radiology

Research Interests

Risk syndrome for psychosis; Psychosis prodrome; Attenuated psychosis disorder

Current Projects

Predictors and Mechanisms of Conversion to Psychosis (MH082022)
Aspirin vs placebo for the psychosis prodrome
D-serine for the psychosis prodrome (MH074356)

Dutetrabenzine for tardive dyskinesia
Huperzine for cognitive enhancement in schizophrenia (MH083436)


Research Summary

Dr. Woods conducts studies aiming to improve prediction of which prodromal adolescents and young adults will progress to frank psychosis and which will remit. He also conducts studies aiming to improve the treatment of current symptoms and to prevent progression.


Selected Publications

  • Woods SW, Walsh BA, Hawkins KA, Miller TJ, Saksa JR, D'Souza DC, Pearlson GD, Javitt DC, McGlashan TH, Krystal JH. Glycine treatment of the risk syndrome for psychosis: Report of two pilot studies. European Neuropsychopharmacology 2013;23:931-940 PMCID: PMC3867209
  • Woods SW, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Mathalon DH, Perkins DO, Seidman LJ, Tsuang M, Walker EF, McGlashan TH. Psychotropic medication use in youth at clinical high risk for psychosis: comparison of baseline data from two research cohorts 1998-2005 and 2008-2011. Schizophrenia Research 2013;148:99-104 PMCID: PMC3867209
  • Woods SW, Walsh BC, Addington J, Cadenhead KS, Cannon TD, Cornblatt BA, Heinssen R, Perkins DO, Seidman LJ, Tarbox SI, Tsuang M, Walker EF, McGlashan TH. Current status specifiers for patients at clinical high risk for psychosis. Schizophrenia Research 2014;158:69-75 PMID: 25012147 NIHMS 612662

Edit Profile